«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《慢性病学杂志》[ISSN:1674-8166/CN:11-5900/R]

卷:

21

期数:

2020年09期

页码:

1314-1316

栏目:

论　著

出版日期:

2020-09-28

文章信息/Info

Title:

Effect of high-dose calcitriol shock therapy on secondary hyperparathyroidism in uremia

作者:

王海涛

江苏省宿迁市泗阳县人民医院肾脏内科，江苏 宿迁 223700

Author(s):

WANGHai-tao

Departmentof Nephrology,People’sHospitalofSiyangCounty,SuqianCity,Jiangsu 223700，China Correspondingauthor:WANGHai-tao,E-mail:565263924@qq.com

关键词:

尿毒症; 继发性甲状旁腺功能亢进症; 骨化三醇; 冲击疗法

Keywords:

Uremia;  Secondary hyperparathyroidism;  Calcitriol;  Shock therapy

分类号:

R698

DOI:

-

摘要:

目的 探讨大剂量骨化三醇治疗尿毒症继发性甲状旁腺功能亢进症的效果。方法 回顾性分析江苏省宿 迁市泗阳县人民医院2017年1月至2018年2月收治的92例行血液透析的尿毒症继发性甲状旁腺功能亢进症患者 的临床资料，患者均给予实验室检查、影像学检查，甲状旁腺激素（PTH）均>600pg/ml。根据治疗方法的不 同分为研究组和对照组，每组46例。研究组给予大剂量骨化三醇（2 μg）冲击疗法，对照组给予常规剂量 （0.5 μg）治疗，观察两组治疗前后的PTH、血钙、血磷水平和治疗总有效率。结果 治疗前，两组患者 PTH、血钙与血磷比较，差异无统计学意义（P>0.05）；治疗后，研究组患者PTH、血磷水平低于对照组，血钙 水平高于对照组，差异有统计学意义（P<0.05）。研究组总有效率为93.48%，高于对照组的78.26%，差异有统 计学意义（P<0.05）。随访6个月，对照组未出现药物不良反应；研究组出现眩晕2例，恶心4例，一过性高钙血 症1例，均自然缓解，未见肝肾功能明显减退等不良反应。结论 大剂量骨化三醇在尿毒症继发性甲状旁腺功能 亢进症治疗中的应用能够降低患者的PTH和血磷水平，升高血钙水平，具有一定的安全性。

Abstract:

Objective To investigate the effect of high-dose calcitriol shock therapy on secondary hy-perparathyroidism in uremia. Methods Clinical data of92 uremia patients with secondary hyperpara-thyroidism treated in People’s Hospital of Siyang County from January 2017 to February 2018 were retrospectively analyzed. All patients were given laboratory examination and imaging examination, and their levels of parathyroid hormone （PTH）were higher than600 pg/ml. According to the different treatment methods, they were divided into study group and control group, 46 cases in each group. The study group was given high-dose calcitriol shock therapy（2 μg）, and the control group was giv-en conventional dose therapy（0.5 μg）. PTH, blood calcium and blood phosphorus levels before and after treatment in the two groups were observed, and the total effective rates of treatment were com-pared.Results Before treatment, there was no significant difference in PTH, blood calcium and blood phosphorus between the two groups（P>0.05）; after treatment, the PTH and blood phosphorus levels of the study group were lower than those of the control group, and the blood calcium level was high-er than that of the control group（P<0.05）. The total effective rate of the study group was significant higher than that of the control group（93.48% vs.78.26%,P<0.05）. After 6 months of follow-up, no adverse drug reactions occurred in the control group. In the study group, there were 2 cases of dizzi-ness, 4 cases of nausea, and 1 case of transient hypercalcemia, and all of them resolved naturally. No adverse reactions such as marked decrease in liver and kidney function were observed. Conclusion The application of high-dose calcitriol in the treatment of secondary hyperparathyroidism in uremia pa-tients can reduce PTH, blood phosphorus levels, and increase blood calcium levels with certain safety.

参考文献/References:

[1] 于跃,张凌,姚力,等.继发性甲状旁腺功能亢进症行甲状旁腺切 除术后并发甲状腺功能亢进1例[J].中国血液净化,2014,13(12): 864-866. [2] 伦立德,刘东,高卓,等.甲状旁腺切除对尿毒症继发性甲状旁腺 功能亢进症患者生存质量的影响[J].中国血液净化,2014,13(1): 23-26. [3] 丁舒,陈伟,任洁,等.骨化三醇冲击治疗尿毒症继发性甲状旁腺 功能亢进疗效观察[J].药物流行病学杂志,2015,24(8):448-450. [4] 韩年华,包民慧,谈晓峰.骨化三醇冲击治疗尿毒症继发性甲状旁 腺功能亢进疗效观察[J].齐齐哈尔医学院学报,2013,34(18): 2665-2666. [5] 王涛,王芳,高红宇.碳酸镧结合骨化三醇治疗维持性血液透析患 者继发性甲状旁腺功能亢进的临床研究[J].实用临床医药杂志, 2017,21(15):195-196,198. [6] Vulpio C, Bossola M. Parathyroid Nodular Hyperplasia and Responsiveness to Drug Therapy in Renal Secondary Hyperparathyroidism: An Open Question [J]. Ther Apher Dial,2018,22(1):11-21. [7] 宁玉东,王田田,薄少军,等.三种影像学检查联用在继发性甲状 旁腺功能亢进症术前定位的诊断价值研究[J].临床耳鼻咽喉头颈 外科杂志,2017,31(18):1408-1411. [8] 赵双红,吕晶,尹爱萍.慢性肾脏病伴继发性甲状旁腺功能亢进的 研究进展[J].中国临床研究,2014,27(6):751-752,756. [9] 李土凤,黄宇戈,张慧琼,等.维生素D依赖性佝偻病ⅠA型1例并 文献复习[J].中国儿童保健杂志,2019,27(5):577-578. [10] 汪永辉,薛卡明,汪贤聪,等.骨化三醇长程冲击疗法治疗难治性 继发性甲状旁腺功能亢进37例临床观察[J].临床肾脏病杂志, 2015,15(11):692-694.

备注/Memo

备注/Memo:

作者简介：王海涛，大学本科，副主任医师，研究方向：肾性贫血的治疗 通信作者：王海涛，E-mail:565263924@qq.com

常用功能

更新日期/Last Update: 2020-09-28